The Effect of Laughter Yoga in Beta Thalassaemia Major Patients: a Randomised Controlled Trial
Launched by ATATURK UNIVERSITY · May 12, 2025
Trial Information
Current as of November 13, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at how laughter yoga can help patients with Beta Thalassemia Major, a type of blood disorder. The researchers want to see if participating in laughter yoga can improve feelings of fatigue, depression, anxiety, stress, sleep quality, and even reduce the number of blood transfusions these patients need.
To be eligible for this study, participants must be over 18 years old, diagnosed with Beta Thalassemia Major, and able to do the yoga exercises without any serious physical issues. They should also own a smartphone and have mild to moderate levels of depression, anxiety, or stress. If you join, you can expect to participate in laughter yoga sessions along with other patients, which could help improve your overall well-being. If you're interested, please note that the trial is not yet recruiting participants, so stay tuned for updates on when you can sign up.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Diagnosed with Beta Thalassaemia major,
- • Over 18 years of age,
- • No hearing and communication problems,
- • The one with the smartphone
- • Routine treatment with iron chelators, folic acid and magnesium
- • Do not have a physical problem that will prevent yoga exercises (bleeding haemorrhoids, all kinds of hernia, persistent cough, incontinence, severe back pain, hypertension, major psychiatric diseases, pregnancy, flu, epilepsy, surgery in the last 3 months, etc.)
- • Depression-Anxiety-Stress scale scores of 10 and above for depression (depressed), 8 and above for anxiety (anxious), 15 and above for stress (stressed)
- • Beta thalassaemia major patients who volunteered to participate in the study will be included in the study sample
- Exclusion Criteria:
- • Who doesn't practice laughter yoga
- • Changing the treatment regime
- • Patients who wish to withdraw from the study
About Ataturk University
Atatürk University, located in Erzurum, Turkey, is a prominent academic institution dedicated to advancing research and education across various disciplines. As a clinical trial sponsor, the university leverages its extensive resources and expertise to facilitate innovative medical research aimed at improving patient outcomes and contributing to the global body of health knowledge. Committed to ethical standards and rigorous scientific methodologies, Atatürk University collaborates with healthcare professionals, researchers, and regulatory bodies to ensure the integrity and efficacy of its clinical trials, ultimately enhancing the quality of care and driving advancements in medical science.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Batman, Turkey
Patients applied
Trial Officials
Emine Kıyak, Professor
Study Director
Ataturk University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported